Cinnamon’s reputation as a blood sugar helper is one of the most repeated claims in the supplement world. It’s also one of the most misunderstood.
The honest answer is: it depends on which study you’re looking at.
Some randomized controlled trials show a measurable drop in fasting blood glucose. Others show no effect at all. Below is a breakdown of what the research actually says, and why the results aren’t as consistent as marketing copy often suggests.
What the Research Actually Shows
The evidence on cinnamon and blood sugar is genuinely mixed, and that inconsistency is well documented in the clinical literature itself.
Trials showing a benefit. A 2013 systematic review and meta-analysis of 10 randomized controlled trials (543 participants) found that cinnamon doses ranging from 120 mg to 6 g per day, taken for 4 to 18 weeks, reduced fasting plasma glucose by an average of roughly 24.6 mg/dL. The same analysis found improvements in total cholesterol, LDL, and HDL, but no significant effect on HbA1c, the marker that reflects blood sugar control over the previous 2 to 3 months.
Trials showing no benefit. An earlier 2008 meta-analysis of 5 randomized controlled trials (282 participants) found that cinnamon did not significantly change A1C, fasting blood glucose, or lipid levels in people with type 1 or type 2 diabetes.
Recent umbrella review. A 2025 umbrella review pooling 21 meta-analyses (139 comparisons) concluded that cinnamon is associated with improvements in fasting blood glucose and lipid profiles overall, with larger effects at doses above 1.5 g per day and shorter intervention periods of 2 months or less. Effects on insulin resistance and HbA1c remained less consistent across the pooled studies.
Taken together, this points to a real but modest and inconsistent effect on fasting glucose, not a reliable effect on long-term glycemic control.
Why the Results Are So Inconsistent
Several factors make it hard to draw a single conclusion from cinnamon research.
Species isn’t always specified. The National Center for Complementary and Integrative Health (NCCIH) notes that interpreting cinnamon studies is difficult because it’s often unclear which species, Ceylon or Cassia, or which part of the plant was actually tested. Since the two types differ in their active compound concentrations, this matters for comparing results across studies.
Dose and duration vary widely. Trials have used anywhere from 120 mg to 6 g per day, over periods from a few weeks to several months. Higher doses over shorter periods have shown larger effects in pooled analyses, which suggests a dose-response relationship that individual small trials aren’t powered to detect.
Study populations differ. Some trials enrolled people with well-controlled type 2 diabetes, others enrolled people with prediabetes or metabolic syndrome. Baseline blood sugar status changes how much room there is for a measurable effect.
Sample sizes are small. Most individual trials include well under 100 participants, which is one reason meta-analyses that pool multiple trials tend to find effects that single studies miss, or fail to replicate.
Mechanistic Evidence vs Clinical Evidence
It’s worth separating two different kinds of evidence here.
Mechanistic evidence comes from lab and animal studies showing how cinnamon compounds, particularly cinnamaldehyde and certain polyphenols, may influence insulin signaling and glucose uptake at the cellular level. This research helps explain why an effect is biologically plausible.
Clinical evidence comes from trials in actual people, like the ones above. This is what tells us whether the mechanism translates into a measurable, real-world result.
Cinnamon has reasonably strong mechanistic evidence and moderate, inconsistent clinical evidence. That combination is common in the supplement space, and it means the ingredient is promising rather than proven.
What This Means If You’re Considering a Cinnamon Supplement
Cinnamon is not a treatment for diabetes, and it should not replace prescribed medication or medical monitoring. The research above reflects its use as a possible adjunct, not a substitute for standard care.
If you’re managing blood sugar with medication, especially insulin or sulfonylureas, adding cinnamon on top of that regimen can compound the glucose-lowering effect. This is worth reviewing with your doctor or pharmacist before starting.
For most healthy adults using cinnamon supplements within typical labeled doses, the main practical consideration isn’t blood sugar, it’s coumarin exposure from Cassia-type cinnamon, which is a separate safety issue tied to long-term use.
FAQs
Does cinnamon actually lower blood sugar?
Some meta-analyses show a modest reduction in fasting blood glucose, particularly at higher doses over shorter periods. Other trials show no significant effect. The evidence is real but inconsistent, not a guaranteed result.
Does cinnamon help with HbA1c?
Most meta-analyses have not found a significant effect on HbA1c, the marker of long-term blood sugar control, even in trials that showed short-term fasting glucose improvements.
Is Ceylon or Cassia cinnamon better for blood sugar?
Most clinical trials don’t clearly specify which species was tested, which makes direct comparison difficult. Ceylon is generally preferred for regular supplementation because of its much lower coumarin content, independent of any blood sugar effect.
How much cinnamon do studies use for blood sugar?
Trial doses range widely, from about 120 mg to 6 g per day, taken for anywhere from 4 weeks to several months. There’s no single confirmed effective dose.
Can cinnamon replace my diabetes medication?
No. Cinnamon has not been shown to reliably treat diabetes and should never replace prescribed medication. Any use alongside diabetes medication should be discussed with a healthcare provider due to the risk of additive blood sugar-lowering effects.
Is it safe to take cinnamon with metformin or other diabetes medication?
This should be discussed with your doctor or pharmacist first. Combining cinnamon with glucose-lowering medication may increase the risk of hypoglycemia, and your provider can help you monitor for this safely.
Sources
- NCCIH — Cinnamon: Usefulness and Safety, National Institutes of Health
- Allen RW, et al. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis, Annals of Family Medicine, 2013
- Baker WL, et al. Effect of cinnamon on glucose control and lipid parameters, Diabetes Care, 2008
- Umbrella review of meta-analyses of cinnamon in metabolic disease, PMC, 2025
Cinnamon’s blood sugar effects are strongest in trials using higher, standardized doses, similar to what’s found in the products below. See our picks for the best Ceylon cinnamon supplements, selected for low coumarin content and third-party testing.
